glp-1 agonists in development GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction Mechanisms by which GLP-1 agonists
Description
Due to the retrospective nature of the data, other confounding factors may have affected the results as well
The once-daily human GLP-1 analogue liraglutide impacts appetite and energy intake in patients with type 2 diabetes after short-term treatment
Evaluate projects that Pfizer will further drop in the rankings to fifth place by 2030
Use of incretin-based drugs and risk of cholangiocarcinoma: scandinavian cohort study
Back VanItallie, TB, Nufert, TH (Oct 2003) 'Ketones: Metabolism's ugly duckling', Nutrition Reviews , 61/10, 327-41
